A Double-Blind, Randomized, Placebo-Controlled, Parallel Group Trial on the Efficacy and Safety of PanhematinTM in the Treatment of Acute Attacks of Porphyria

Project: Other project

StatusActive
Effective start/end date11/12/138/31/20

Funding

  • Recordati Rare Diseases Inc: $109,091.00